CUV 0.31% $14.57 clinuvel pharmaceuticals limited

Ann: Ceasing to be a substantial holder, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 632 Posts.
    lightbulb Created with Sketch. 301
    Shorters and long term holders alike have learned that Clinuvel management is incompetent and happy to lie.

    unlike holders over the past 5 years, shorters have done very well. Death, taxes and Clinuvel failing to hit a timeline.

    reading the latest XP patent rejection is comical. Didn’t rosenfeld promise board renewal early 24, and a video presentation? He is so proud of his new role as chair of Clinuvel that he is keeping it secret on his LinkedIn profile. If only Clinuvel had a CBM division to assist him.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.